Zimbabwe has declined a significant American health deal valued at $367m (272 million pounds) over five years due to the United States' demand for sensitive biological samples.
This rejection became public after a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".
An official representative later explained that the US was demanding access to health data for scientific study and commercial purposes but refused to share the resulting advantages from any future medical innovations.
"We must now begin the challenging and unfortunate task of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had provided over $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged continued dialogue to find a agreement agreeable to all parties so the country's critical HIV programme can be sustained.
Broader Implications
This rejection follows a comparable case in Kenya, where a high court blocked a related health funding agreement following concerns were filed about the security of Kenyans' health data.
Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
USAID had overseen assistance for the US government, but Trump stated its expenditure was "inefficient" and his government was pursuing government-to-government deals to enhance transparency and responsibility.
As per statements, 16 nations in Africa have so far agreed to similar health pacts, representing more than $18.3bn in new funding.
Details of the Declined Agreement
The money for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation could have provided extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on HIV treatment via US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"Our nation was requested to surrender its biological resources and data over an extended period, with no equivalent assurance of access to any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," his statement read.
"In essence, our country would provide the raw materials for medical research with no certainty that the final treatments would be accessible to our citizens should a future health crisis emerge."
Sovereignty and Global Health
He also pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were upending systems already set up via the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to deal with potential global health emergencies.
"This system is designed to guarantee that when a nation provides its samples, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to create them."
The government's concerns over the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome further discussions with our US partners on how future collaboration could be structured in a manner that honours the independence and interests of both nations."
Health Experts Reaction
Medical experts stated it understood the government's concerns, but recommended that talks need to persist given that a large portion of the nation's HIV programmes relied on external financing.
"Where specific concerns arise, including those involving data governance or agreement terms, these can often be addressed via detailed discussion and mutually agreed protections," the group said.
The situation emphasises the complex debate between accepting much-needed international aid and protecting national sovereignty in an ever more data-driven world.